Study guide

7.8 Blood Product Administration

NCLEX-RN Registered Nurse

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the NCLEX-RN Exam Next Generation NCLEX (NGN) Clinical Judgment Measurement Model (NCJMM) How to Use This Course

2 Chapter 2: Management of Care

2.1 Legal Rights and Responsibilities 2.2 Advance Directives and Self-Determination 2.3 Informed Consent Protocols 2.4 Client Advocacy and Rights (HIPAA) 2.5 Assignment, Delegation, and Supervision 2.6 Five Rights of Delegation 2.7 Scope of Practice (RN vs LPN vs UAP) 2.8 Ethical Practice Principles

3 Chapter 3: Safety and Infection Prevention and Control

3.1 Standard Precautions and Hand Hygiene 3.2 Transmission-Based Precautions (Contact, Droplet, Airborne) 3.3 PPE Donning and Doffing Sequences 3.4 Fall Prevention and Restraints 3.5 Fire Safety (RACE/PASS) 3.6 Disaster Triage and Emergency Response

4 Chapter 4: Health Promotion and Maintenance

4.1 Growth and Development (Erikson/Piaget) 4.2 Developmental Stages: Infancy through Older Adult 4.3 Maternal and Newborn Care (Antepartum) 4.4 Intrapartum Care and Fetal Monitoring 4.5 Postpartum Care (BUBBLE-HE) 4.6 Health Screening Guidelines 4.7 Immunization Schedules

5 Chapter 5: Psychosocial Integrity

5.1 Therapeutic Communication Techniques 5.2 Non-Therapeutic Communication (What to Avoid) 5.3 Anxiety Disorders and Mental Health Concepts 5.4 Schizophrenia: Hallucinations and Delusions 5.5 Depression and Suicide Assessment 5.6 Substance Misuse and Withdrawal 5.7 Grief and End-of-Life Care

6 Chapter 6: Basic Care and Comfort

6.1 Mobility and Hazards of Immobility 6.2 Assistive Devices (Crutches, Canes, Walkers) 6.3 Nutrition and Diet Therapy 6.4 Enteral Nutrition (Tube Feeding) 6.5 Bowel Elimination and Ostomy Care 6.6 Urinary Elimination and Catheter Care

7 Chapter 7: Pharmacological and Parenteral Therapies

7.1 Medication Administration Rights 7.2 Medication Calculations 7.3 High-Alert Medications: Insulins 7.4 High-Alert Medications: Anticoagulants 7.5 High-Alert Medications: Opioids 7.6 High-Alert Medications: Digoxin and Electrolytes 7.7 IV Therapy and Complications 7.8 Blood Product Administration 7.9 Total Parenteral Nutrition (TPN)

8 Chapter 8: Reduction of Risk Potential

8.1 Laboratory Values: Hematology (CBC) 8.2 Laboratory Values: Metabolic Panel (BMP) 8.3 Laboratory Values: Coagulation Studies 8.4 Vital Signs and Trend Recognition 8.5 Perioperative Care (Pre-Op and Post-Op) 8.6 Nasogastric Tubes and Therapeutic Procedures

9 Chapter 9: Physiological Adaptation

9.1 Fluid Imbalances (Hypovolemia and Hypervolemia) 9.2 Arterial Blood Gases (ABGs) and Acid-Base Balance 9.3 Medical Emergencies: Stroke (CVA) 9.4 Medical Emergencies: Myocardial Infarction (MONA) 9.5 Diabetic Emergencies (Hypoglycemia and DKA) 9.6 Respiratory Conditions (COPD, Pneumonia) 9.7 Cardiac Conditions (Heart Failure) 9.8 Neurological Conditions (Seizures)

7.8 Blood Product Administration

Key Takeaways Explain This Topic AI

Before the transfusion starts, verify the patient and the unit at the bedside (patient ID, ABO/Rh, unit number, expiration) using the facility's process, often a two-person check by staff the organization designates

Use 0.9% sodium chloride with blood; other solutions only if FDA-approved for use with blood or documented safe, and never lactated Ringer's or other calcium-containing fluids

A transfusion should start before the unit expires and finish within 4 hours after the container is entered (spiked), per the AABB Circular of Information

Acute hemolytic reaction presents with fever, chills, flank pain, and hemoglobinuria - stop transfusion immediately

For adults, a 20-24 gauge catheter suits most transfusions (chosen by vein size); use 18-20 gauge when rapid transfusion is needed, and run red cells more slowly through small catheters (INS 2021)

Last updated: October 2026

Blood transfusion is a potentially life-saving intervention that carries significant risks. The NCLEX heavily tests your knowledge of safe transfusion practices and recognition of transfusion reactions.

Blood Products

  • Product Contains Indications
  • Packed Red Blood Cells (PRBCs) RBCs with minimal plasma Anemia, blood loss
  • Fresh Frozen Plasma (FFP) Clotting factors Coagulopathy, warfarin reversal
  • Platelets Platelet concentrate Thrombocytopenia, bleeding
  • Cryoprecipitate Fibrinogen, Factor VIII DIC, hemophilia A
  • Whole Blood All components Massive hemorrhage (rare)
  • Albumin Plasma protein Volume expansion, hypoalbuminemia
  • Pre-Transfusion Requirements

Before Blood Leaves Blood Bank:

  • Order verified
  • Type and crossmatch completed
  • Patient consent obtained
  • Baseline vital signs documented
  • Patent IV access confirmed (20-24 gauge; 18-20 gauge for rapid transfusion)
  • Bedside Identity Verification

Before the transfusion starts, verify at the bedside (many facilities use a two-person check; the organization decides who may serve as the second checker):

  • Verification Point What to Check
  • Patient identification Name and DOB (ask patient to state)
  • Armband matches Blood bank slip matches armband
  • Blood type ABO and Rh compatible
  • Unit number Blood bag matches slip
  • Expiration date Product not expired
  • Visual inspection No clots, discoloration, or leaks

Document the verification per facility policy before the transfusion begins.

Blood Type Compatibility

ABO Compatibility:

  • Patient Blood Type Can Receive
  • Type O O only (Universal donor for RBCs)
  • Type A A, O
  • Type B B, O
  • Type AB A, B, AB, O (Universal recipient)

Rh Compatibility:

  • Rh negative patients should receive Rh negative blood
  • Rh positive patients can receive either
  • Administration Protocol

Equipment:

  • Blood administration set with in-line filter
  • IV pump (if approved for blood)
  • 0.9% sodium chloride (no other solution in the blood line unless FDA-approved for that use or documented safe)
  • 20-24 gauge IV catheter by vein size (18-20 gauge or larger for rapid transfusion)

Procedure:

  • Prime tubing with Normal Saline
  • Start transfusion slowly: 2 mL/min for first 15 minutes
  • Stay with patient for first 15 minutes
  • Take vital signs: baseline, 15 min, 30 min, end of transfusion
  • Finish the unit within 4 hours after the container is entered (spiked)
  • Document per facility policy

Rate Guidelines:

  • PRBCs: Usually over 2-4 hours
  • Platelets: Usually over 15-30 minutes
  • FFP: Usually over 30 minutes to 2 hours
  • Adjust based on patient tolerance
  • Transfusion Reactions
  • Acute Hemolytic Reaction (Most Severe)
  • Cause: ABO incompatibility - immune destruction of transfused cells
  • Onset: Within minutes to hours
  • Signs/Symptoms Pathophysiology
  • Fever, chills Immune response
  • Flank/back pain RBC destruction in kidneys
  • Chest pain, dyspnea Intravascular hemolysis
  • Hypotension Shock response
  • Hemoglobinuria Free hemoglobin in urine
  • DIC Coagulation cascade activated

Intervention:

  • STOP transfusion immediately
  • Keep IV line open with NEW tubing and saline
  • Stay with patient
  • Notify provider and blood bank STAT
  • Send blood bag and tubing to lab
  • Draw blood samples as ordered
  • Monitor urine output (renal failure risk)
  • Prepare for emergency intervention
  • Febrile Non-Hemolytic Reaction (Most Common)
  • Cause: Antibodies against donor WBCs

Signs: temperature rise ≥1°C (≥1.8°F) or chills/rigors during or within 4 hours after the transfusion; mild dyspnea may occur

Intervention:

  • Stop transfusion
  • Notify provider
  • Rule out hemolytic reaction
  • Antipyretics as ordered

Do not restart unless approved by the transfusion service protocol (patients with repeated, severe febrile reactions may benefit from leukocyte-reduced components in future transfusions)

  • Allergic Reaction
  • Cause: Sensitivity to donor plasma proteins
  • Mild Signs: Urticaria (hives), itching, flushing

Intervention for Mild Reaction:

  • Stop the transfusion
  • Notify provider and transfusion service
  • Administer antihistamine (diphenhydramine) as ordered
  • Restart only if approved by the transfusion service protocol

Anaphylactic Reaction (Severe):

  • Bronchospasm, stridor
  • Angioedema
  • Hypotension, shock

Intervention:

  • Stop transfusion permanently
  • Maintain airway
  • Epinephrine as ordered
  • Full resuscitation if needed
  • Transfusion-Related Acute Lung Injury (TRALI)
  • Cause: Donor antibodies attack recipient lung tissue
  • Signs: Within 6 hours of transfusion
  • Acute respiratory distress
  • Pulmonary edema (non-cardiogenic)
  • Hypoxia
  • Fever

Intervention:

  • Stop transfusion
  • Supportive respiratory care
  • May require mechanical ventilation
  • Circulatory Overload (TACO)
  • Risk Factors: Elderly, heart failure, renal failure

Signs:

  • Dyspnea, orthopnea
  • Jugular vein distension
  • Crackles in lungs
  • Hypertension
  • Prevention: Slow infusion rate, may give furosemide between units
  • Quick Response Guide
  • If You Observe Action
  • Any reaction signs STOP transfusion
  • Fever, chills Rule out hemolytic reaction
  • Hives only Stop; restart only if the transfusion service protocol approves
  • Respiratory distress Stop permanently, call RRT
  • Flank pain, hemoglobinuria Emergency - hemolytic reaction
  • Documentation Requirements
  • Consent obtained
  • Pre-transfusion vital signs
  • Bedside identity verification (per facility policy)
  • Time transfusion started
  • Vital signs at 15 min, 30 min, end
  • Volume transfused
  • Any reactions and interventions
  • Post-transfusion assessment
  • On the Exam
  • Know the verification process
  • 0.9% sodium chloride with blood; never lactated Ringer's
  • Finish within 4 hours of spiking the bag
  • Recognize hemolytic reaction signs
  • First action for any reaction: STOP the transfusion